Stryker
SYK
Stryker (SYK) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $3.69
- EPS estimate
- $3.49
- EPS surprise
- +5.78%
- Revenue surprise
- +0.15%
- Revenue
- $6.6B
- Revenue estimate
- $6.6B
- Reported
- Jul 30, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $3.49 | $3.69 | +5.78% | $6.6B | SEC |
| Q1 2026 | Apr 30, 2026 | $2.98 | $2.60 | −12.77% | $6.0B | SEC |
| Q4 2025 | Jan 29, 2026 | $4.40 | $4.47 | +1.68% | $7.2B | SEC |
| Q3 2025 | Oct 30, 2025 | $3.13 | $3.19 | +1.82% | $6.1B | SEC |
| Q2 2025 | Jul 31, 2025 | $3.07 | $3.13 | +2.00% | $6.0B | SEC |
| Q1 2025 | May 1, 2025 | $2.71 | $2.84 | +4.63% | $5.9B | SEC |
| Q4 2024 | Jan 28, 2025 | $3.87 | $4.01 | +3.57% | $6.4B | SEC |
| Q3 2024 | Oct 29, 2024 | $2.77 | $2.87 | +3.52% | $5.5B | SEC |
| Q2 2024 | Jul 30, 2024 | $2.79 | $2.81 | +0.66% | $5.4B | SEC |
| Q1 2024 | Apr 30, 2024 | $2.36 | $2.50 | +6.13% | $5.2B | SEC |
| Q4 2023 | Jan 30, 2024 | $3.27 | $3.46 | +5.85% | $5.8B | SEC |
| Q3 2023 | Nov 2, 2023 | $2.43 | $2.46 | +1.04% | $4.9B | SEC |
| Q2 2023 | Aug 3, 2023 | $2.38 | $2.54 | +6.69% | $5.0B | SEC |
| Q1 2023 | May 1, 2023 | $2.00 | $2.14 | +6.88% | $4.8B | SEC |
| Q4 2022 | Jan 31, 2023 | $2.84 | $3.00 | +5.78% | $5.2B | SEC |
| Q3 2022 | Oct 31, 2022 | $2.20 | $2.12 | −3.59% | $4.5B | SEC |
| Q2 2022 | Jul 26, 2022 | $2.27 | $2.25 | −1.06% | $4.5B | SEC |
| Q1 2022 | Apr 28, 2022 | $1.95 | $1.97 | +1.26% | $4.3B | SEC |
| Q4 2021 | Jan 27, 2022 | $2.72 | $2.71 | −0.46% | $4.7B | SEC |
| Q3 2021 | Oct 28, 2021 | $2.28 | $2.20 | −3.36% | $4.2B | SEC |
Quarterly revenue
Frequently asked questions
When did Stryker (SYK) last report earnings?
Stryker last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did SYK beat earnings estimates?
Yes. Stryker reported EPS of $3.69 for Q2 2026 against a $3.49 estimate — a 5.78% beat.
How much revenue did SYK report last quarter?
Stryker reported $6.6B in revenue for Q2 2026, against a consensus estimate of $6.6B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.